CDNA
NASDAQ
$38.37
Caredx Inc (CDNA)
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $33 (-14.00%)
Market Cap
$1.53B
FCF 5Y CAGR
+83.64%
Free Cash Flow Yield
4.53%
Beta (5Y)
1.27
Price Chart
Valuation
Market Cap$1.53B
Forward P/E94.34
P/S3.62
P/B4.74
Profitability
Total Revenue (TTM)$413M
Gross Profit (TTM)$284M
EBITDA-$892K
Profit Margin2.4%
Operating Margin1%
EPS-$0.15
Financial Health
Free Cash Flow Yield4.53%
Growth & Risk
EPS 5Y CAGR-10.97%
Revenue 5Y CAGR+13.29%
FCF 5Y CAGR+83.64%
Beta (5Y)1.27
Sharpe Ratio1.95